Fundraising Fox

Scott Biller

Investor

Venture Partner at GV (Google Ventures)

Boston, Massachusetts

Writes $250K – $50M checks Β· typically $25M

About

Dr. Scott Biller is an Executive Venture Partner at GV with a deep R&D background, having served as Chief Scientific Officer of Agios Pharmaceuticals and held leadership roles at Novartis and Bristol-Myers Squibb. He advises and sits on the boards of several biotech companies including Foghorn, Remix, Rome, and OMass Therapeutics.

Invests in

BiotechMedical Devices

Experience

  1. OMass TherapeuticsBoard Membercurrent2022 β€” present
  2. GVExecutive Venture Partnercurrent2021 β€” presentCambridge, Massachusetts, United States
  3. ROME TherapeuticsBoard Membercurrent2021 β€” present
  4. Gate BioscienceBoard Observercurrent2021 β€” present
  5. Remix TherapeuticsBoard Membercurrent2020 β€” present
  6. Foghorn Therapeutics, IncBoard Membercurrent2020 β€” present
  7. VividionScientific Advisory Board member2019 β€” 2024
  8. Agios PharmaceuticalsScientific Advisory Board member2021 β€” 2023
  9. Agios PharmaceuticalsStrategic Advisor2020 β€” 2021
  10. Agios PharmaceuticalsChief Scientific Officer2010 β€” 2019
  11. Denali TherapeuticsScientific Advisory Board member2015 β€” 2023
  12. Novartis Institutes for BioMedical ResearchVice President, Global Discovery Chemistry2003 β€” 2010
  13. Bristol-Myers SquibbVice President, Pharmaceutical Candidate Optimization2001 β€” 2003
  14. Bristol Myers SquibbDirector, Executive Director, Discovery Chemistry1995 β€” 2001
  15. MITStudent1972 β€” 1976

Education

  1. Massachusetts Institute of TechnologyBS, Chemistry1972 β€” 1976
  2. Columbia UniversityPostdoc, Organic Chemistry1982 β€” 1983
  3. CaltechPhD, Organic Chemistry1976 β€” 1981
  4. Stuyvesant High SchoolHigh School Diploma, Chemistry1968 β€” 1972

Skills & more

Drug Discovery99Medicinal Chemistry56Drug Design40Organic Chemistry52Oncology34Chemistry99Drug Development99Lead Change24Lifesciences16Pharmacology27Cancer12Biochemistry27
+7 moreADMEAssay DevelopmentNeuroscienceOrganic SynthesisLife SciencesPharmaceutical IndustryCRO

From Scott's professional profile.

Same school

Shared employers

Investments

Board seats

Foghorn TherapeuticsOMASS TherapeuticsRemix TherapeuticsRome Therapeutics

Per the firm's website.

Colleagues at GV (Google Ventures)